Medical Research and Clinical Trials

Salk Scientists Uncover Estrogen-Related Receptors as Key to Revitalizing Muscle Energy and Combating Fatigue

• Medical Research and Clinical Trials

Salk Scientists Uncover Estrogen-Related Receptors as Key to Revitalizing Muscle Energy and Combating Fatigue

Raul Delapena Setiawan July 18, 2026

LA JOLLA, CA – May 12, 2025 – In a breakthrough that could redefine the treatment landscape...

Read More Read more about Salk Scientists Uncover Estrogen-Related Receptors as Key to Revitalizing Muscle Energy and Combating Fatigue

GSK Shelves Camlipixant for Chronic Cough, Shifting Focus to IBS Amidst Class Challenges

• Medical Research and Clinical Trials

GSK Shelves Camlipixant for Chronic Cough, Shifting Focus to IBS Amidst Class Challenges

Laily UPN July 18, 2026

London, UK – [Insert Date] – In a significant strategic pivot, British pharmaceutical giant GSK has announced...

Read More Read more about GSK Shelves Camlipixant for Chronic Cough, Shifting Focus to IBS Amidst Class Challenges

A New Dawn in Breast Cancer Treatment: Cambridge Breakthrough Offers 100% Survival for Aggressive Inherited Cancers

• Medical Research and Clinical Trials

A New Dawn in Breast Cancer Treatment: Cambridge Breakthrough Offers 100% Survival for Aggressive Inherited Cancers

Nana July 17, 2026

Cambridge, UK – In a landmark development that could fundamentally alter the treatment landscape for patients with...

Read More Read more about A New Dawn in Breast Cancer Treatment: Cambridge Breakthrough Offers 100% Survival for Aggressive Inherited Cancers

Johnson & Johnson’s Nipocalimab: A New Frontier in Systemic Lupus Erythematosus Treatment

• Medical Research and Clinical Trials

Johnson & Johnson’s Nipocalimab: A New Frontier in Systemic Lupus Erythematosus Treatment

Lina Hope July 17, 2026

Johnson & Johnson (J&J) is poised to make significant inroads in the treatment of Systemic Lupus Erythematosus...

Read More Read more about Johnson & Johnson’s Nipocalimab: A New Frontier in Systemic Lupus Erythematosus Treatment

Revolutionary Breakthrough: Brain Tumour Diagnosis Slashed from Weeks to Hours, Transforming Patient Care

• Medical Research and Clinical Trials

Revolutionary Breakthrough: Brain Tumour Diagnosis Slashed from Weeks to Hours, Transforming Patient Care

Sagoh July 17, 2026

NOTTINGHAM, UK – In a medical advancement poised to redefine the landscape of brain tumour care, scientists...

Read More Read more about Revolutionary Breakthrough: Brain Tumour Diagnosis Slashed from Weeks to Hours, Transforming Patient Care

Trellis Bioscience Secures $9 Million Series C Funding to Advance Novel Treatment for Chronic Prosthetic Joint Infections

• Medical Research and Clinical Trials

Trellis Bioscience Secures $9 Million Series C Funding to Advance Novel Treatment for Chronic Prosthetic Joint Infections

Suro Senen July 17, 2026

Boston, MA – July 17, 2026 – Trellis Bioscience, a pioneering biotechnology company focused on developing innovative...

Read More Read more about Trellis Bioscience Secures $9 Million Series C Funding to Advance Novel Treatment for Chronic Prosthetic Joint Infections

Unmasking the Dual Threat: Genetics and Treatment Jointly Drive Secondary Cancers in Childhood Survivors

• Medical Research and Clinical Trials

Unmasking the Dual Threat: Genetics and Treatment Jointly Drive Secondary Cancers in Childhood Survivors

Jia Lissa July 17, 2026

Memphis, TN – A groundbreaking study from St. Jude Children’s Research Hospital has fundamentally reshaped our understanding...

Read More Read more about Unmasking the Dual Threat: Genetics and Treatment Jointly Drive Secondary Cancers in Childhood Survivors

MASH Therapeutics Landscape Explodes: Rezdiffra Faces a Multi-Front Assault as Innovation Accelerates

• Medical Research and Clinical Trials

MASH Therapeutics Landscape Explodes: Rezdiffra Faces a Multi-Front Assault as Innovation Accelerates

Ali Ikhwan July 17, 2026

The once-singular treatment option for metabolic dysfunction-associated steatohepatitis (MASH) is rapidly evolving into a dynamic and fiercely...

Read More Read more about MASH Therapeutics Landscape Explodes: Rezdiffra Faces a Multi-Front Assault as Innovation Accelerates

Roche Expands Trontinemab’s Horizon in Alzheimer’s Fight with Pre-Symptomatic Trial and Promising Phase III Data

• Medical Research and Clinical Trials

Roche Expands Trontinemab’s Horizon in Alzheimer’s Fight with Pre-Symptomatic Trial and Promising Phase III Data

Nana Wu July 17, 2026

London, UK – July 25, 2026 – In a significant stride towards a more comprehensive approach to...

Read More Read more about Roche Expands Trontinemab’s Horizon in Alzheimer’s Fight with Pre-Symptomatic Trial and Promising Phase III Data

A New Frontier in Cancer Treatment: IgE Antibodies Harness the Immune System Against Resistant Tumours

• Medical Research and Clinical Trials

A New Frontier in Cancer Treatment: IgE Antibodies Harness the Immune System Against Resistant Tumours

Nana Wu July 16, 2026

London, UK – In a significant stride towards more targeted and less toxic cancer therapies, scientists at...

Read More Read more about A New Frontier in Cancer Treatment: IgE Antibodies Harness the Immune System Against Resistant Tumours